Jump to content

PKfool fooled again:International scamster..aganavasi maro agnanam


AnnaGaru

Recommended Posts

Gedela is Chintal ka baap :roflmao:

a chintal gadu ante sarle "comedy piece " anukunnam.....eedi endira nayana decoitism at peaks......international scam batch antha digaru ga state loki......DEcoit gadi gang anukunte ippudu PK gadi agnanam tho

kurrodu prapancha sastravettale bolta kottinchadu.........INTERNATIONAL LEVEL annai scam level......bloomberg lo kuda vachindi vaadi scam gurinchi.....

 

vaadu JANASENA MAIN master mind entra ni pindakudu? muta gattesi munchestadu andarni..

 

ఉత్తరాంధ్ర కోఆర్డినెరటర్ డా.గేదెల శ్రీను బాబు 

Vinodam1_zpse4770c68.gif

 

 

 

Fake Science: Face behind biggest of all — ‘40 countries, million articles’

https://indianexpress.com/article/india/face-behind-biggest-of-all-40-countries-million-articles-fake-research-srinubabu-gedela-omics-5266830/

 

https://www.bloomberg.com/news/features/2017-08-29/medical-journals-have-a-fake-news-problem

https://www.ftc.gov/enforcement/cases-proceedings/152-3113/federal-trade-commission-v-omics-group-inc

 

https://retractionwatch.com/2016/08/26/u-s-government-group-sues-publisher-charging-it-with-deceiving-researchers/

 

U.S. government agency sues publisher, charging it with deceiving researchers

2000px-US-FederalTradeCommission-Seal.svgThe U.S. Federal Trade Commission has charged a publisher of hundreds of academic journals with deceiving readers about reviewing practices, publication fees, and the nature of its editorial boards.

 

The defendants in this case used false promises to convince researchers to submit articles presenting work that may have taken months or years to complete, and then held that work hostage over undisclosed publication fees ranging into the thousands of dollars…It is vital that we stop scammers who seek to take advantage of the changing landscape of academic publishing.

http://blogs.discovermagazine.com/neuroskeptic/2016/08/29/omics-ftc-predatory-publisher/#.W8jr7mhKg2x

 

https://www.the-scientist.com/the-nutshell/us-court-issues-injunction-against-open-access-publisher-omics-30581

 

If successful, the FTC suit could result in the court asking OMICS to return money to some researchers, among other penalties:

https://retractionwatch.com/2016/08/26/u-s-government-group-sues-publisher-charging-it-with-deceiving-researchers/

'Predatory' Online Journals Lure Scholars Who Are Eager to Publish
 

US Court Issues Injunction Against Open-Access Publisher OMICS

The Federal Trade Commission won an initial ruling against the India-based publisher for allegedly misleading researchers and for misrepresenting journal impact factors and editorial boards. 

 

Junk science publisher ordered to stop ‘deceptive practices’

The FTC’s complaint charges the defendants, OMICS Group Inc., iMedPub LLC, Conference Series LLC, and Srinubabu Gedela, with multiple violations of the FTC Act’s prohibition on deceptive acts or practices. 

Operation made false claims and hid publishing fees, FTC alleges

federal court has granted a preliminary injunction requested by the Federal Trade Commission, temporarily halting the deceptive practices of academic journal publishers charged by the agency with making false claims about their journals and academic conferences, and hiding their publishing fees, which were up to several thousand dollars.

The preliminary injunction against OMICS Group Inc., iMedPub LLC, Conference Series LLC, and their CEO, director, and owner, Srinubabu Gedela stems from a complaint the FTC filed last year that names Gedela and his three companies as defendants.

https://www.ftc.gov/enforcement/cases-proceedings/152-3113/federal-trade-commission-v-omics-group-inc

 

https://www.ftc.gov/news-events/press-releases/2017/11/ftc-halts-deceptive-practices-academic-journal-publishers

 

http://lawprofessors.typepad.com/intfinlaw/aml/page/11/

 

https://www.thestar.com/news/world/2017/11/23/junk-science-publisher-ordered-to-stop-deceptive-practices.html

 

https://www.researchgate.net/post/Can_I_trust_OMICS_publishing_group

 

 

Link to comment
Share on other sites

orey saduku savara anedi anduke......chintal batch antha rendu engilipisu mukkalu cheppagae eedu flat anukunta...kanisam basic check kuda telidu....

 

tenor.gif

 

 

44065462_2013447808714707_70099222481485

 

http://blogs.sciencemag.org/pipeline/archives/2017/09/15/the-ugly-state-of-the-literature-these-days

 

In Hyderabad, where Omics’s headquarters are spread over 250,000 square feet in two buildings, Gedela is convinced of a win. “The FTC is following the fake news,” he says. He exudes nervous energy as he walks the halls, rarely making eye contact with employees and cutting off conversations abruptly. For years he’s promoted a postdoctoral study he did at Stanford to boost his credibility. The school confirms he held a position for five months, an unusually short time, in 2009, a year after starting Omics. Gedela is cagey when asked about the details, saying he left early to return to India to build his company. But when he hooks his laptop up to a large TV screen in his office to show emails proving the dates of his Stanford sojourn, he accidentally projects an adviser’s email threatening to terminate his contract after saying he took vastly more vacation than allowed. When questioned, he brushes the discrepancy off.

 

Link to comment
Share on other sites

aadiki PENALITES vaasi pobutundi chustunte....anduke state lo kotta avatam ettadu

/****************

The agency says a preliminary review of bank records shows researchers spent at least $26.6 million on publication and conference registration fees from 2009 to 2015.

 

The FTC has asked for a preliminary injunction and is seeking unspecified monetary reimbursement for academics who claim to have been duped into publishing. 

 

 

Link to comment
Share on other sites

3 minutes ago, baggie said:

veedi gurinchi munde telusu bro...chala pedda scamster eedu...conferences peru tho dabbulu dobabdu chala...inthaki pk gadiki veediki link enti?

JANASENA main UA incharge....PK right laga feel avutunnadu...

munchi dobbutadu PK tho patu pilla sainiks ni...

 

DpxwXqFVAAEPaXz.jpg

Link to comment
Share on other sites

7 hours ago, baggie said:

international farudster eedu....maaku kuda calls vachayi conference committee lo members avandi ani....chal dobbey ani cheppam

veedu oka movie kuda produce chesadu anukunta.....priyamani main lead lo vuntundi...veedu scam latho easy ga 500cr varaku sampadinchadu....

Link to comment
Share on other sites

3 hours ago, paruchuriphani said:

veedu oka movie kuda produce chesadu anukunta.....priyamani main lead lo vuntundi...veedu scam latho easy ga 500cr varaku sampadinchadu....

500C naa ante around 100million usd. nenu antha expect cheyaledu around 10million usd emo ankunta unna.

Link to comment
Share on other sites

PK venaka main vallalo eedu okadu anta....edu mamulu fakest kadu baboi....Srikakulam ni muta gatti chuttesi ammestadu....

PK taruvata JD Lakshminaraya ni kuda trap chesadu ante e range talent o chudochu...

 

EEDIKI RUSHIKONDA lo franklin templeton babdulu land ivvaledu ani PK gadu allegations CBN meda....kharmai..

 

 

by the way eedu DR ani add chesukuntunadu....ediki PHD ayyinda asalu?.

 

Link to comment
Share on other sites

Fake Science: Face behind biggest of all — ‘40 countries, million articles’

Fake Science part-II: Srinubabu Gedela is the CEO of OMICS, labelled as one of the largest “predatory publishers” of research articles on topics in medicine, pharmaceuticals, engineering, technology and management for charges ranging from $149 to $1,819.

132
Shares
Written by Shyamlal Yadav | Hyderabad | Updated: July 22, 2018 10:01:26 am
Inside India’s fake research paper shops: pay, publish, profit
 
Fake Science part-II: OMICS, from this building in Hyderabad, hosts over 700 journals and faces action in US.

“We have published nearly a million articles, including those from conference proceedings. This year, we are organising more than 2,000 conferences, 500 symposiums and 500 workshops in 40 countries.”

Inside an imposing glass-cased building in Hyderabad’s Gachibowli, the 36-year-old face behind more than 780 research journals and companies operating in 40 countries, has confidence written all over it.

But behind all the plans, Srinubabu Gedela is at the centre of a storm that’s threatening his business empire. Gedela is the CEO of OMICS, labelled as one of the largest “predatory publishers” of research articles on topics in medicine, pharmaceuticals, engineering, technology and management for charges ranging from $149 to $1,819.

READ | 1 journal to 1,500 in 10 years: Hyderabad is hub of pay & publish

On May 1, the US Federal Trade Commission (FTC) filed a motion in the District Court of Nevada, seeking “preliminary injunction and other equitable relief” against OMICS. It alleged that most of the claims found on websites of OMICS journals — on peer reviews, list of editors, access to credible databases — are “phony”.

fake-science-part-2.jpg

On July 13, Rajesh Malhotra, professor of orthopaedics at AIIMS-Delhi, filed a police complaint against OMICS for allegedly falsely naming him as an editor of one of its journals.

Gedela, however, is unfazed. Speaking to The Indian Express, he described the FTC as “illiterates”. He claimed that all the charges against OMICS are “completely wrong” (Read full interview).

But The Indian Express spoke to experts who have been tracking OMICS over the years and found that they were far from impressed by such claims.

Asked to identify the biggest predatory publisher in India, S C Lakhotia, professor emeritus at Banaras Hindu University (BHU), told The Indian Express: “I understand that the OMICS group is based in India and most of its journals would qualify to be in that category.” (Read full interview)

Until last year, Lakhotia was a member of a UGC committee formed to assess such journals.

Jeffrey Beall, a former librarian at the University of Colorado in Denver who coined the term “predatory publishing” eight years ago, was more direct.

READ | Inside India’s fake research paper shops: pay, publish, profit

“The worst case is OMICS International based in Hyderabad. It publishes hundreds of low-quality, open-access journals… It uses deceptive practices and does not carry out a proper peer review, publishing scientific papers without proper quality control. It has hurt many academics throughout the world, giving a bad name to India,” Beall told The Indian Express (Read full interview).

Gedela claimed that Beall has a bias. “Because of open access journals, their jobs are at stake,” he said, referring to librarians. He claimed that his company had sent a notice seeking $1 billion in damages to Beall but did not pursue it because “he is not capable of paying the damages”.

READ | V-Cs, AIIMS, IIT professors on list: ‘Students sent it, we don’t know’

However, a number of experts in India told The Indian Express that their names were wrongly used by OMICS. Besides, The Indian Express found, at least 177 OMICS journals did not list their ISSN, the standardised international ID code.

Sanjeev Mishra, Director, AIIMS-Jodhpur, is listed in the “proceedings” of at least two OMICS conferences – September 15-17, 2014, in Lucknow and October 20-21, 2014, in the US. Mishra told The Indian Express that he “never attended” them.

Sarman Singh, Director, AIIMS-Bhopal, is listed in two OMICS conferences. “Neither me nor any of my students attended these conferences,” Singh said.

OMICS boss, Srinubabu Gedela, Srinubabu Gedela OMICS, OMICS database, fake research paper, professors named in fake research paper, Fake Science part-II: Srinubabu Gedela owns OMICS. (Express Photo)

Rakesh Bhatnagar, Vice-Chancellor, BHU, said he “did not attend” the four OMICS conferences where his name was listed.

Malhotra, from AIIMS-Delhi, who is listed as an editor of OMICS’s Journal of Osteoarthritis, said: “I am neither on the rolls of OMICS nor am I the editor of any of those journals. I didn’t even know that they were using my name on their website. In fact, my affiliation on the site is not accurate. It was possibly lifted from the cover of one of my earlier books.”

Gedela completed his B. Pharm and M.Tech (Biotechnology) from Andhra University and post-doctoral degree from Stanford University in the US. Hailing from Allana village in Andhra’s Srikakulam district, he established his first company OMICS Group Inc in Nevada in 2007, started his first journal Journal of Proteomics & Bioinformatics in 2008, and returned to India in 2009.

The Indian version was founded as OMICS Online Publishing Pvt Ltd in Hyderabad. In 2015, the company’s name was changed to OMICS International Pvt Ltd.

EXPLAINED | How the pay-and-publish business works

Registrar of Companies (RoC) records show that Gedela is linked today to a web of subsidiaries and entities, such as OMICS Entertainment Pvt Ltd, Versant Online Solutions and Srinu Sci Technol BioSoft Pvt Ltd.

Records show that OMICS Entertainment took a loan of Rs 5 crore from Punjab National Bank in March 2016; Versant showed a net loss of Rs 4.68 crore in 2015-16 after taxes; and, Srinu Sci Technol BioSoft’s turnover in 2015-16 was Rs 16.89 lakh.

But Gedela claimed that when it came to OMICS, “our revenue from India is almost zero”. “Europe has 40 per cent of our business, US has 7-8 per cent, China has nine. India is not our market. Out of 3,000 conferences we are conducting this year, not a single one is in India,” he said.

This is why, he said, his companies have nothing to do with education regulatory authorities in India, such as UGC.

“Our articles from India are very few, less than 0.01 percent… 99.99 percent of articles are from outside. So we are not concerned about India, indexing, UGC, etc. This is all nonsense. Our services are all export and there is no business from India,” he said.

Gedela said that he formed entities over the last two years in the UK and Singapore, including Meetings International, Allied Academics Ltd, Euroscion Ltd, Pulsus Group Ltd. He is also linked to two Delaware-based companies, iMedPub LLC and Conference Series LLC.

Gedela has informed the Nevada court that OMICS Group, iMedPub, Conference Series, Allied Academies, Pulsus, Trade Sci, SciTechnol and EuroSciCon are subsidiaries of OMICS International.

In Nevada, one of the charges levelled by FTC is that OMICS falsely claimed that “their publications are included in NIH’s indexing databases” and used the logo “to advertise their journals”. The trade commission was referring to PubMed Central (PMC), a free full-text archive of biomedical and life sciences journal literature at the US National Institutes of Health’s National Library of Medicine.

Gedela confirmed that some OMICS journals were removed from PubMed in 2013. “It was also because of Jeffrey Beall’s blog,” he said.

Link to comment
Share on other sites

xxxxx jeevitam....edi meda world wide investigation chestunaru researchers valla pani manesi to expose him....:roflmao:

attantodni Franklin templeton tho polchi CBN meda allegations Pk gaadu..

 

SkinnyFewIndusriverdolphin-size_restrict

https://www.readfearn.com/2018/01/all-those-omics-linked-companies-in-one-place/

 

 

But here’s a list of all the organisations I’ve come across linked to OMICS and Srinubabu Gedela. I’ll update it as I find more.

Link to comment
Share on other sites

1 hour ago, ravindras said:

chiranjeevi tries pretend like gentleman surrounded by greedy people like allu aravind

pawan pretend like intellectual surrounded by fake intellectuals. 

chiranjeevi is a greedy person who pretends like gentleman surrounded by greedy people like allu aravind

pawan is a fake intellectual who pretends like intellectual surrounded by fake intellectuals. 

Link to comment
Share on other sites

world researchers ni katta katti TITLI tufan range titti teesina mana janasainik...inka illiterate PK gadu eediki oka comedy pice laga tagiluntadu eediki

vallu research lu manesi eedi kosam picholla laga terugutunnaruuuu

7CpF.gif

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Link to comment
Share on other sites

Injunction against Hyderabad’s OMICS to stop ‘deceptive practices’

prasad R. Prasad
November 25, 2017 20:16 IST
Updated: November 25, 2017 20:18 IST
Srinubabu Gedela

Srinubabu Gedela  

 

The lawsuit accused OMICS of deceptive business practices

The Federal Trade Commission (FTC) has won the first court battle against the Hyderabad-based OMICS Group, which publishes over 700 journals. A federal district court in the District of Nevada granted a preliminary injunction temporarily halting the deceptive business practices of OMICS. The FTC had charged OMICS with making false claims about their journals and academic conferences.

The “preliminary injunction prohibits the defendants from making misrepresentations regarding their academic journals and conferences, including that specific persons are editors of their journals or have agreed to participate in their conferences. It also prohibits the defendants from falsely representing that their journals engage in peer review, that their journals are included in any academic journal indexing service, or any measurement of the extent to which their journals are cited. It also requires that the defendants clearly and conspicuously disclose all costs associated with submitting or publishing articles in their journals”.

 

The lawsuit

The lawsuit against OMICS Group and Chief Executive Officer Srinubabu Gedela was filed in August 2016 accusing the defendants of deceptive business practices.

The FTC had alleged that the defendants deceptively claimed that their journals provide authors with rigorous peer review and have editorial boards made up of prominent academics. In fact, however, many articles are published with little or no peer reviewing and many individuals represented to be editors have not agreed to be affiliated with the journals.

The FTC also alleged that the defendants seldom tell authors about publishing fees, which is significantly high, and once submitted, OMICS does not allow authors to withdraw their manuscripts. This makes it nearly impossible to submit to other respected journals for publication. The FTC also alleged that there were misleading claims made by OMICS about impact factor and indexing in PubMed.

“Papers published in OMICS journals are peer reviewed as per international standards,” claims Mr. Gedela in an email to The Hindu. But contrary to his claims, a couple of sting operations have revealed how poor or non-existent the peer-reviewing process is for papers published in OMICS journals.

“The Court ordered [that] if OMICS is following any deceptive practice identified by FTC then OMICS should stop that deceptive practice. But as communicated [to you over phone], FTC has failed to prove any allegations or deceptive practice of OMICS even during two years’ of their investigation. We are not misrepresenting anything,” he claims. “In my opinion, the FTC team is trying its level best to support its stand as it has become a prestige issue.”

In response to a question by The Hindu that OMICS has been ordered to remove all misleading claims from its websites Mr. Gedela says: “Yes, Court [has given a] preliminary injection order to remove any misrepresentation or misleading claims. OMICS is following that and not [putting out] any misleading information or claims.”

 

Peer regard

Mr. Gedela claims that PubMed is restricted to the U.S. “There are so many indexing databases for different countries and for different subjects,” he says. Unfortunately, the indexing databases that Mr. Gedela is referring to such as the Index Copernicus is treated with scorn by the scientific community.

“The lawsuit and judge’s order were not an attempt to regulate the journals or conferences themselves. We want to make clear that this has nothing to do with the content. Nothing in this order goes to what they can or can’t publish in terms of content. This is about how they are soliciting would-be academics to publish in their journals,” Gregory Ashe, a senior attorney for the FTC’s division of financial practices told Retraction Watch.

“The intention behind the preliminary injunction is to stop misrepresentation and to get the required information from us. It is not to halt any of our operations in the United States,” Mr. Kishore Vattikoti, Senior legal counsel for OMICS International said in an email to The Hindu.

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...